Correlation Between Lipocine and WENA New
Can any of the company-specific risk be diversified away by investing in both Lipocine and WENA New at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and WENA New into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and WENA New, you can compare the effects of market volatilities on Lipocine and WENA New and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of WENA New. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and WENA New.
Diversification Opportunities for Lipocine and WENA New
Poor diversification
The 3 months correlation between Lipocine and WENA is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and WENA New in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WENA New and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with WENA New. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WENA New has no effect on the direction of Lipocine i.e., Lipocine and WENA New go up and down completely randomly.
Pair Corralation between Lipocine and WENA New
Given the investment horizon of 90 days Lipocine is expected to generate 0.63 times more return on investment than WENA New. However, Lipocine is 1.6 times less risky than WENA New. It trades about 0.0 of its potential returns per unit of risk. WENA New is currently generating about -0.17 per unit of risk. If you would invest 498.00 in Lipocine on November 3, 2024 and sell it today you would lose (66.00) from holding Lipocine or give up 13.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 24.8% |
Values | Daily Returns |
Lipocine vs. WENA New
Performance |
Timeline |
Lipocine |
WENA New |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lipocine and WENA New Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and WENA New
The main advantage of trading using opposite Lipocine and WENA New positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, WENA New can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WENA New will offset losses from the drop in WENA New's long position.Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
WENA New vs. Austevoll Seafood ASA | WENA New vs. Romana Food Brands | WENA New vs. Paranovus Entertainment Technology | WENA New vs. Edgewell Personal Care |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
CEOs Directory Screen CEOs from public companies around the world |